3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Insulin Resistance
1
Endocrine System Diseases
1
Interventions
parathyroid hormone-related peptide (1-36)
2
Musculoskeletal Manipulations
2
Cisplatin
2
niraparib
1
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
anlotinib
1
adrenosterone
1
Ultrasonography
1
Thalidomide
1
Sunitinib
1
Parathyroid Hormone-Related Protein
1
Parathyroid Hormone
1
Paclitaxel
1
Octreotide
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Eating
1
Doxorubicin
1
Diffusion
1
Dexamethasone
1
Dehydroepiandrosterone
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endocrine System Diseases
×
adrenosterone
×
Clear all
NCT05263557
2023-07-25
DIMOXIS
Royal College of Surgeons, Ireland
Phase NA
Unknown
20 enrolled